BIOGEN INC. (BIIB) Operating Income (Loss) USD 2010 - 2022

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Biogen Inc. quarterly Operating Income (Loss) history and growth rate from 2010 to 2022.
  • Biogen Inc. Operating Income (Loss) for the quarter ending March 31, 2022 was $611 M, a 37.3% decline year-over-year.
  • Biogen Inc. Operating Income (Loss) for the twelve months ending March 31, 2022 was $2.48 B, a 33.1% decline year-over-year.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly Data (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $2.48 B $611 M -$363 M -37.3% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-03
Q4 2021 $2.84 B $587 M +$918 M Oct 1, 2021 Dec 31, 2021 10-K 2022-02-03
Q4 2021 $2.84 B $2.84 B -$1.71 B -37.6% Jan 1, 2021 Dec 31, 2021 10-K 2022-02-03
Q3 2021 $1.92 B $794 M -$292 M -26.9% Jul 1, 2021 Sep 30, 2021 10-Q 2021-10-20
Q2 2021 $2.22 B $486 M -$1.49 B -75.4% Apr 1, 2021 Jun 30, 2021 10-Q 2021-07-22
Q1 2021 $3.7 B $974 M -$846 M -46.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $4.55 B -$331 M -$2.11 B -119% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-03
Q4 2020 $4.55 B $4.55 B -$2.49 B -35.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-03
Q3 2020 $6.66 B $1.09 B -$720 M -39.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-20
Q2 2020 $7.38 B $1.97 B +$18.6 M +0.95% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-22
Q1 2020 $7.36 B $1.82 B +$317 M +21.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-22
Q4 2019 $7.04 B $1.78 B +$335 M +23.2% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-03
Q4 2019 $7.04 B $7.04 B +$1.15 B +19.6% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-03
Q3 2019 $6.71 B $1.81 B +$109 M +6.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-21
Q2 2019 $6.6 B $1.96 B +$743 M +61.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-22
Q1 2019 $5.86 B $1.5 B -$32 M -2.09% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-23
Q4 2018 $5.89 B $1.44 B -$23.1 M -1.58% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-03
Q4 2018 $5.89 B $5.89 B +$543 M +10.2% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-03
Q3 2018 $5.91 B $1.7 B +$43.7 M +2.64% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-22
Q2 2018 $5.87 B $1.21 B +$12.2 M +1.02% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-24
Q1 2018 $5.86 B $1.53 B +$510 M +49.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-24
Q4 2017 $5.35 B $1.47 B +$579 M +65.2% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-06
Q4 2017 $5.35 B $5.35 B +$194 M +3.77% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-06
Q3 2017 $4.77 B $1.65 B +$229 M +16% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-23
Q2 2017 $4.54 B $1.2 B -$260 M -17.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-24
Q1 2017 $4.8 B $1.02 B -$354 M -25.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-24
Q4 2016 $5.15 B $888 M -$281 M -24% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-06
Q4 2016 $5.15 B $5.15 B +$261 M +5.33% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-06
Q3 2016 $5.43 B $1.43 B +$53.5 M +3.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-24
Q2 2016 $5.38 B $1.46 B +$227 M +18.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-25
Q1 2016 $5.15 B $1.38 B +$261 M +23.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-25
Q4 2015 $4.89 B $1.17 B +$8.45 M +0.73% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-01
Q4 2015 $4.89 B $4.89 B +$919 M +23.1% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-01
Q3 2015 $4.88 B $1.37 B +$219 M +19% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-26
Q2 2015 $4.66 B $1.23 B +$244 M +24.7% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-21
Q1 2015 $4.42 B $1.12 B +$447 M +66.5% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-21
Q4 2014 $3.97 B $1.16 B +$502 M +76.3% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-02
Q4 2014 $3.97 B $3.97 B +$1.46 B +57.9% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-02
Q3 2014 $3.47 B $1.15 B +$468 M +68.4% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-21
Q2 2014 $3 B $989 M +$326 M +49.2% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-24
Q1 2014 $2.68 B $671 M +$161 M +31.5% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-24
Q4 2013 $2.52 B $658 M +$212 M +47.7% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-03
Q4 2013 $2.52 B $2.52 B +$660 M +35.5% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-03
Q3 2013 $2.3 B $685 M +$149 M +27.9% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-22
Q2 2013 $2.15 B $663 M +$157 M +31% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-23
Q1 2013 $2 B $511 M +$141 M +38.2% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-23
Q4 2012 $1.86 B $446 M +$36.4 M +8.9% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-04
Q4 2012 $1.86 B $1.86 B +$131 M +7.61% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-04
Q3 2012 $1.82 B $535 M +$46.8 M +9.57% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-28
Q2 2012 $1.77 B $506 M +$94.9 M +23.1% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-25
Q1 2012 $1.68 B $369 M -$46.9 M -11.3% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-25
Q4 2011 $1.72 B $409 M +$53.9 M +15.2% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-06
Q4 2011 $1.72 B $1.72 B +$476 M +38.1% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-06
Q3 2011 $1.67 B $488 M +$294 M +152% Jul 1, 2011 Sep 30, 2011 10-Q 2012-10-25
Q2 2011 $1.38 B $411 M +$14.9 M +3.77% Apr 1, 2011 Jun 30, 2011 10-Q 2012-07-24
Q1 2011 $1.36 B $416 M +$113 M +37.1% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-01
Q4 2010 $1.25 B $355 M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-05
Q4 2010 $1.25 B $1.25 B Jan 1, 2010 Dec 31, 2010 10-K 2013-02-05
Q3 2010 $194 M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-28
Q2 2010 $396 M Apr 1, 2010 Jun 30, 2010 10-Q 2011-07-26
Q1 2010 $304 M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.